Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration
Go back to Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration| (NASDAQ: CTOR) | Delayed: 0.76 +0.02 (2.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.74 | 52 Week High | $ | |||
| Open | $0.76 | 52 Week Low | $ | |||
| Day High | $0.76 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $ | |||
| Volume | 7,575 | |||||
| (NASDAQ: CTXR) | Delayed: 0.57 -0.03 (5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $2.50 | |||
| Open | $0.61 | 52 Week Low | $0.40 | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.57 | EPS | $0.00 | |||
| Volume | 178,647 | |||||
